PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study reveals new way to unlock blood-brain barrier, potentially opening doors to treat brain and nerve diseases

Study reveals new way to unlock blood-brain barrier, potentially opening doors to treat brain and nerve diseases
2024-11-25
(Press-News.org) New York, NY [November 25, 2024]—Researchers at the Icahn School of Medicine at Mount Sinai have developed an innovative approach—demonstrated in mouse models and isolated human brain tissue—to safely and effectively deliver therapeutics into the brain, providing new possibilities for treating a wide range of neurological and psychiatric diseases.

Published in the November 25 online issue of Nature Biotechnology [https://doi.org/10.1038/s41587-024-02487-7], the study introduces a first-of-its-kind blood-brain barrier-crossing conjugate (BCC) system, designed to overcome the protective barrier that typically blocks large biomolecules from reaching the central nervous system (CNS).

The blood-brain barrier is a natural protective shield that prevents harmful substances from entering the brain. However, it also blocks the delivery of life-saving drugs, creating a significant challenge in treating conditions like amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, addiction, and many other CNS disorders.

The BCC platform takes advantage of a specialized biological process called γ-secretase-mediated transcytosis to deliver large therapeutic molecules, like oligonucleotides and proteins, directly into the brain through a simple intravenous injection.

“The blood-brain barrier is an essential defense mechanism, but it also presents a significant challenge for delivering drugs to the brain,” says co-corresponding senior author Yizhou Dong, PhD, Professor of Immunology and Immunotherapy, and a member of the Icahn Genomics Institute and the Marc and Jennifer Lipschultz Precision Immunology Institute, at Icahn Mount Sinai. “Our BCC platform breaks this barrier, allowing biomacromolecules, including oligonucleotides, to reach the CNS safely and efficiently.”

The study showed that when the researchers injected a compound called BCC10 linked to specialized genetic tools known as antisense oligonucleotides into mice, it successfully reduced the activity of harmful genes in the brain. In a transgenic mouse model of ALS (a motor neuron disease), the treatment significantly lowered levels of the disease-causing gene called Sod1 and its associated protein. Similarly, a different antisense oligonucleotide linked to BCC10 greatly reduced another gene, Mapt, which encodes the tau protein and is a target for the treatment of Alzheimer’s disease and other dementias.

BCC10 proved to be highly effective at delivering these genetic tools to the brain, improving their ability to silence harmful genes in different models and even in samples of excised human brain tissue studied in the laboratory. Importantly, the treatment was well tolerated in mice, causing little or no damage to major organs at the tested doses, say the investigators.

Despite recent progress in the field, there is still a pressing need for technologies that can bypass the blood-brain barrier and improve the delivery of biomacromolecule-based therapies to the central nervous system via systemic administration.

“Our platform could potentially solve one of the biggest hurdles in brain research—getting large therapeutic molecules past the blood-brain barrier safely and efficiently,” says co-corresponding senior author Eric J. Nestler, MD, PhD, Nash Family Professor of Neuroscience, Director of The Friedman Brain Institute, and Dean for Academic Affairs of Icahn Mount Sinai, and Chief Scientific Officer of the Mount Sinai Health System. “This development has the potential to advance treatments for a broad range of brain diseases.”

Next, the investigators plan to conduct further studies in large animal models to validate the platform and develop its therapeutic potential.

The paper is titled “Intravenous administration of blood-brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system.”

The remaining authors, all with Icahn Mount Sinai except where indicated, are Chang Wang, MD; Siyu Wang, PhD; Yonger Xue, PhD; Yichen Zhong, BS (PhD Candidate); Haoyuan Li, MD; Xucheng Hou, PhD; Diana D. Kang, BS (PhD Candidate/Icahn Mount Sinai and Ohio State University); Zhengwei Liu, PhD; Meng Tian, PhD; Leiming Wang, PhD; Dinglingge Cao, PhD; Yang Yu, PhD (Ohio State University), Jayce Liu, BS (PhD Candidate, Ohio State University), Xiaolin Cheng, PhD (Ohio State University), Tamara Markovic, PhD; Alice Hashemi, BS; Brian H. Kopell, MD, and Alexander W. Charney, MD, PhD.

To view details on competing interests, see: [https://doi.org/10.1038/s41587-024-02487-7].

-####-

 

About the Icahn School of Medicine at Mount Sinai 

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight- member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.   

Ranked 11th nationwide in National Institutes of Health (NIH) funding and among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 4,560 full-time scientists, educators, and clinicians work within and across 45 academic departments and 38 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, as well as gastrointestinal and liver diseases. 

Icahn Mount Sinai offers highly competitive MD, PhD, and Master’s degree programs, with current enrollment of more than 1,200 students. It has the largest graduate medical education program in the country, with more than 2,685 clinical residents and fellows training throughout the Health System. In addition, more than 560 postdoctoral research fellows are in training within the Health System. 

A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinai’s technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into healthcare products and services that benefit the public.  

Icahn Mount Sinai’s commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the School’s programs.  

Through the Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.  

The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.  

------------------------------------------------------- 

* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

END


[Attachments] See images for this press release:
Study reveals new way to unlock blood-brain barrier, potentially opening doors to treat brain and nerve diseases Study reveals new way to unlock blood-brain barrier, potentially opening doors to treat brain and nerve diseases 2 Study reveals new way to unlock blood-brain barrier, potentially opening doors to treat brain and nerve diseases 3

ELSE PRESS RELEASES FROM THIS DATE:

Viking colonizers of Iceland and nearby Faroe Islands had very different origins, study finds

Viking colonizers of Iceland and nearby Faroe Islands had very different origins, study finds
2024-11-25
The ancient Vikings certainly had the travel bug. Between the late eighth century and approximately 1050 CE, they roamed the Atlantic in their longships all the way to Newfoundland, Labrador, and Greenland, as well as exploring the Mediterranean and continental Eurasia. Among the places the Vikings are known to have settled were the Faroe Islands, an archipelago of 18 islands in the North Atlantic. They probably weren’t the first to do so: archaeologists have found evidence that these islands had been inhabited since approximately 300 CE, possibly ...

One in 20 people in Canada skip doses, don’t fill prescriptions because of cost

2024-11-25
Affordability in Canada affects not just groceries but also medications, with 1 in 20 people unable to take their medications as prescribed because of cost, found new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241024. Prescription medications are not universally covered under Canada’s 13 provincial and territorial health insurance systems. In 2021, Canadian households paid more than $7.4 billion out of pocket for prescription medications.  The study, which included a nationally representative ...

Wildlife monitoring technologies used to intimidate and spy on women, study finds

Wildlife monitoring technologies used to intimidate and spy on women, study finds
2024-11-25
Remotely operated camera traps, sound recorders and drones are increasingly being used in conservation science to monitor wildlife and natural habitats, and to keep watch on protected natural areas. But Cambridge researchers studying a forest in northern India have found that the technologies are being deliberately misused by local government and male villagers to keep watch on women without their consent. Cambridge researcher Dr Trishant Simlai spent 14 months interviewing 270 locals living around the Corbett Tiger Reserve, a national park in northern India, including many women from nearby villages. His report, published today in the journal Environment and Planning ...

Around 450,000 children disadvantaged by lack of school support for color blindness

2024-11-24
Around 450,000 children are being failed by the UK education system because they have a special educational need and disability (SEND) that is effectively unrecognised by most schools and local education authorities, an author has warned. Supporting Colour Blindness in Education and Beyond, by author Marie Difolco, shines a spotlight on a commonly-overlooked SEND in modern classrooms: colour blindness (also known as colour vision deficiency, or CVD). She also warns that many myths surround this condition, with many people believing it just means not being able to tell the ...

Reality check: making indoor smartphone-based augmented reality work

Reality check: making indoor smartphone-based augmented reality work
2024-11-23
Osaka, Japan – Smartphone-based augmented reality, in which visual elements are overlaid on the image of a smartphone camera, are extremely popular apps. These apps allow users to see how furniture would look in their house, or navigate maps better, or to play interactive games. The global phenomenon Pokémon GO, which encourages players to catch digital creatures through their phone, is a well-known example. However, if you want to use augmented reality apps inside a building, prepare to lower your expectations. ...

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain
2024-11-22
Study sought to better understand how humans evolved to become skilled at thinking about others Newer parts of the brain that support social interactions are connected to and in constant communication with the ancient amygdala First study to map with fMRI never-before-seen details of the brain’s social cognitive network CHICAGO --- We’ve all been there. Moments after leaving a party, your brain is suddenly filled with intrusive thoughts about what others were thinking. “Did they think I talked too much?” “Did my joke offend them?” “Were ...

Black men — including transit workers — are targets for aggression on public transportation, study shows

Black men — including transit workers — are targets for aggression on public transportation, study shows
2024-11-22
Black men on buses and trains — whether as passengers or transit workers — face hostile encounters that threaten their sense of safety and well-being, according to a new study by a Keough School of Global Affairs sociologist. By reinforcing racist tropes that they are dangerous or invisible, these encounters can also erode Black men’s sense of dignity and self-worth. “Black men who want to go to work, school, appointments, visit others, or do any of the other things that people use public transport for, find the experience to be degrading rather than liberating,” said Gwendolyn Purifoye, assistant professor of racial justice and conflict transformation in ...

Troubling spike in severe pregnancy-related complications for all ages in Illinois

2024-11-22
Increase in annual rates of obesity were largest by far: 7.8% in 2016 to 22.3% in 2023 Vaginal birth complications increased 22.4%; cesarean birth complications increased 48.9% Non-Hispanic Black mothers faced more than double the rate of severe complications compared to non-Hispanic white mothers Illinois data reflects national increases in obesity, hypertensive disorders of pregnancy and gestational diabetes in pregnant people of all ages CHICAGO --- A new study from Northwestern Medicine reveals a troubling ...

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

2024-11-22
Alcohol use was the most common predictor of escalating cannabis vaping among youth and young adults, independent of demographic factors, according to research by UTHealth Houston published this month in the journal Social Science & Medicine.  Cannabis vaping is the use of electronic cigarette delivery of liquid tetrahydrocannabinol (THC), a concentrated form of cannabis that has been extracted and diluted into a liquid solution.Vaping cannabis has grown in popularity among young people in the U.S., according to ...

Need a landing pad for helicopter parenting? Frame tasks as learning

2024-11-22
New Haven, Conn. — Parents are much less likely to intervene when their young children are getting dressed or performing other simple chores if those tasks are framed as learning opportunities, according to a new study by Yale researchers.   Media reports and academic literature suggest that overparenting — a style of parenting in which adults persistently take over tasks or solve problems that would be developmentally appropriate for children to resolve on their own — is becoming ...

LAST 30 PRESS RELEASES:

How do monkeys recognize snakes so fast?

Revolutionizing stent surgery for cardiovascular diseases with laser patterning technology

Fish-friendly dentistry: New method makes oral research non-lethal

Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)

A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets

New scan method unveils lung function secrets

Searching for hidden medieval stories from the island of the Sagas

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

Human-related activities continue to threaten global climate and productivity

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Unraveling the power and influence of language

Gene editing tool reduces Alzheimer’s plaque precursor in mice

TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies

Twisted Edison: Bright, elliptically polarized incandescent light

Structural cell protein also directly regulates gene transcription

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

Brain map clarifies neuronal connectivity behind motor function

Researchers find compromised indoor air in homes following Marshall Fire

Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

[Press-News.org] Study reveals new way to unlock blood-brain barrier, potentially opening doors to treat brain and nerve diseases